- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Milignant Gliomas in Australia
Total 675 results
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Histiocytic and Dendritic Cell Neoplasm | Recurrent Langerhans Cell Histiocytosis | Recurrent Lymphoma | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant... and other conditionsUnited States, Puerto Rico, Australia
-
EpimAb Biotherapeutics (Suzhou)Co., Ltd.RecruitingAdvanced/Metastatic Solid Tumors | Relapse/Refractory LymphomaChina, Australia
-
Bristol-Myers SquibbCompletedMalignant Solid TumorUnited States, France, Italy, Australia, Canada, Germany, Netherlands
-
Klinikum Klagenfurt am WörtherseeTerminatedUnresectable Malignant Solid Neoplasm | Bystander Effect | Abscopal Effect | Bulky TumorsAustria
-
Dr. Vera TrommetCompletedBreast Neoplasm Malignant FemaleAustria
-
Association of Research on the Biology of Liver...Completed
-
ViralyticsCompletedMalignant MelanomaAustralia
-
University of SydneyThe Brain Cancer GroupNot yet recruitingGlioblastoma MultiformeAustralia
-
Wellmarker BioCovanceRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid TumorKorea, Republic of, Australia
-
Novo Nordisk A/SCompleted
-
Shanghai Fosun Pharmaceutical Industrial Development...TerminatedAdvanced Cancer | Solid Tumors | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States, Australia
-
BeiGeneActive, not recruitingLocally Advanced and Metastatic Solid TumorsChina, Taiwan, United States, Australia
-
University of CalgaryRecruitingRecurrent or Progressive Diffuse Intrinsic Pontine GliomaCanada, Australia, New Zealand
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
Otto Wagner HospitalMedtronic Spine LLCRecruitingLung Neoplasm MalignantAustria
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
University of SydneyCooperative Trials Group for Neuro-OncologyActive, not recruitingGlioblastoma MultiformeUnited States, Australia
-
Redx Pharma PlcMerck Sharp & Dohme LLCCompletedAdvanced Solid TumoursUnited Kingdom, Australia
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Medical University of ViennaRecruitingLocally Advanced and Metastatic Prostate CancerAustria
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Alpine Immune Sciences, Inc.TerminatedLymphoma | Advanced Solid TumorUnited States, Australia
-
Immunocore LtdRecruitingAdvanced MelanomaUnited States, Australia
-
PrECOG, LLC.AstraZeneca; University of Sydney; Thoracic Oncology Group Australasia (TOGA)Active, not recruitingMesothelioma | Malignant Pleural Mesothelioma | Pleural MesotheliomaUnited States, Australia, New Zealand
-
National Cancer Institute (NCI)RecruitingMalignant Glioma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia, Canada
-
AmgenActive, not recruitingNon-squamous Non-small Cell Lung Cancer | Epithelial Ovarian Cancer | Claudin 6-positive Advanced/Metastatic Malignant Solid TumorsUnited States, Australia, Switzerland
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
Queensland Institute of Medical ResearchMerck Sharp & Dohme LLC; Royal Brisbane and Women's Hospital; Princess Alexandra... and other collaboratorsRecruitingGlioblastoma Multiforme | Astrocytoma, Grade IVAustralia
-
Bristol-Myers SquibbNektar TherapeuticsTerminatedEwing Sarcoma | Ependymoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | High-grade Glioma | Leukemia and Lymphoma | Miscellaneous Brain Tumors | Miscellaneous Solid Tumors | Relapsed, Refractory Malignant NeoplasmsUnited States, Australia, France, Germany, Italy, Spain
-
Medical University of GrazCompleted
-
Novartis PharmaceuticalsCompletedcMET Dysegulation Advanced Solid TumorsAustria, Denmark, Sweden, United Kingdom, Spain, Germany, Netherlands, United States
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Trans Tasman Radiation Oncology GroupUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...CompletedLymph Node Disease | Malignant MelanomaAustralia, New Zealand, Netherlands, Brazil
-
AmgenCompletedAdvanced Solid TumorsCanada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood Malignant NeoplasmUnited States, Canada, Australia, Puerto Rico, Switzerland
-
Immix Biopharma Australia Pty LtdActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Solid Tumor, AdultUnited States, Australia
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced CancerSpain, Argentina, United States, Korea, Republic of, Taiwan, Belgium, Romania, Germany, United Kingdom, Australia, Brazil, Canada, China, Czechia, Denmark, France, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Mexico, Netherlands, ... and more
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Turkey, United Kingdom, Switzerland, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria